Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
2.690
+0.180 (7.17%)
At close: Jan 22, 2026, 4:00 PM EST
2.690
0.00 (0.00%)
Pre-market: Jan 23, 2026, 6:33 AM EST
Iovance Biotherapeutics Market Cap
Iovance Biotherapeutics has a market cap or net worth of $1.07 billion as of January 23, 2026. Its market cap has decreased by -54.20% in one year.
Market Cap
1.07B
Enterprise Value
819.53M
1-Year Change
-54.20%
Ranking
Category
Stock Price
$2.69
Market Cap Chart
Since February 26, 2015, Iovance Biotherapeutics's market cap has increased from $244.60M to $1.07B, an increase of 336.57%. That is a compound annual growth rate of 14.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 996.40M | -8.06% |
| Dec 31, 2025 | 1.08B | -51.95% |
| Dec 31, 2024 | 2.26B | 8.40% |
| Dec 29, 2023 | 2.08B | 106.29% |
| Dec 30, 2022 | 1.01B | -66.33% |
| Dec 31, 2021 | 3.00B | -55.99% |
| Dec 31, 2020 | 6.81B | 94.85% |
| Dec 31, 2019 | 3.49B | 220.44% |
| Dec 31, 2018 | 1.09B | 87.59% |
| Dec 29, 2017 | 581.10M | 34.67% |
| Dec 30, 2016 | 431.50M | 16.84% |
| Dec 31, 2015 | 369.30M | 50.98% |
| Feb 26, 2015 | 244.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MoonLake Immunotherapeutics | 1.11B |
| Phathom Pharmaceuticals | 1.11B |
| Zenas BioPharma | 1.10B |
| Palvella Therapeutics | 1.09B |
| Theravance Biopharma | 1.05B |
| ARS Pharmaceuticals | 1.04B |
| ArriVent BioPharma | 1.04B |
| GH Research | 1.04B |